|
Volumn 110, Issue 2, 2009, Pages 218-230
|
Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration
a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FENTANYL;
MORPHINE;
OPIATE;
NARCOTIC ANALGESIC AGENT;
CLINICAL FEATURE;
CONSULTATION;
DIAGNOSTIC PROCEDURE;
EPIDURAL ANESTHESIA;
HEALTH CARE PERSONNEL;
HEALTH SURVEY;
HUMAN;
INTERVENTION STUDY;
LIPOPHILICITY;
MEDICAL EXPERT;
PHYSICAL EXAMINATION;
POSITIVE END EXPIRATORY PRESSURE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROPHYLAXIS;
RESPIRATION DEPRESSION;
REVIEW;
RISK ASSESSMENT;
SPINAL ANESTHESIA;
SUSTAINED DRUG RELEASE;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DELAYED RELEASE FORMULATION;
EVIDENCE BASED MEDICINE;
EXPERT WITNESS;
NEUROMUSCULAR BLOCKING;
OXYGEN THERAPY;
PATIENT CONTROLLED ANALGESIA;
REGIONAL ANESTHESIA;
RESPIRATORY FAILURE;
ANALGESIA, EPIDURAL;
ANALGESIA, PATIENT-CONTROLLED;
ANALGESICS, OPIOID;
ANESTHESIA, CONDUCTION;
DELAYED-ACTION PREPARATIONS;
EVIDENCE-BASED MEDICINE;
EXPERT TESTIMONY;
FENTANYL;
HUMANS;
MORPHINE;
NEUROMUSCULAR BLOCKADE;
OXYGEN INHALATION THERAPY;
RESPIRATORY INSUFFICIENCY;
|
EID: 61549134824
PISSN: 00033022
EISSN: 15281175
Source Type: Journal
DOI: 10.1097/ALN.0b013e31818ec946 Document Type: Article |
Times cited : (159)
|
References (0)
|